| Execution period | Vesting over 4 years; exercisable within 1 year of vesting. |
|---|
BSE filing, NSE: GANECOS. Summary written from the filing by ALFA Finder's alert engine.
Ganesha Ecosphere Ltd: key numbers
- Share price
- ₹1,031.90
- Market cap
- ₹2,765 Cr
- Revenue (annual)
- ₹1,482 Cr
- Net profit (annual)
- ₹38.21 Cr
- P/E (TTM)
- 48.9×Sector 49.0×
- Promoter holding
- 39.33%+0.00% QoQ
- FII holding
- 10.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ganesha Ecosphere Ltd
All →Ganesha Ecosphere Board Meeting Date
Ganesha Ecosphere schedules a 31 October 2026 board meeting for unaudited quarterly and half-yearly results. Trading window closed from 01 October until 48 hours after results.
Ganesha Ecosphere Other Announcement
Ganesha Ecosphere Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI Listing Regulations.
Ganesha Ecosphere Regulatory Approval
Ganesha Ecosphere's subsidiary received FSSAI approval to manufacture food-grade rPET at its fourth production line in Warangal, Telangana.
- rPET production line
- 1.0 line
Ganesha Ecosphere Other Announcement
Ganesha Ecosphere Limited submitted the Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent for the quarter ended September 30, 2026.
Ganesha Ecosphere Employee Stock Options
Ganesha Employee Welfare Trust acquired 1,653 shares and sold 110 shares of Ganesha Ecosphere Ltd via open market transactions.
Ganesha Ecosphere Management Change
Ganesha Ecosphere Ltd announced the appointment of Mr. Rajiv Kumar Saxena as a Non-Executive Independent Director, approved by shareholders at the 37th AGM.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date